C. Kähler

发表

Treatment of pulmonary arterial hypertension (PAH): updated Recommendations of the Cologne Consensus Conference 2011.

W. Haefeli, S. Rosenkranz, H. Ghofrani, 2011, International journal of cardiology.

Spicae aetheroleum in uncomplicated acute bronchitis: a double-blind, randomised clinical trial

C. Kähler, T. Dereziński, J. Bocian-Sobkowska, 2017, Wiener Medizinische Wochenschrift.

Chronic Obstructive Pulmonary Disease (COPD)

C. Kähler, S. Desole, 2008 .

Telehealth mitigates COPD disease progression compared to standard of care: a randomized controlled crossover trial

T. Brack, M. Kohler, M. Tamm, 2021, Journal of internal medicine.

Risk stratification strategy and assessment of disease progression in patients with pulmonary arterial hypertension: Updated Recommendations from the Cologne Consensus Conference 2018.

R. Ewert, H. ten Freyhaus, M. Hoeper, 2018, International Journal of Cardiology.

Subcutaneous implantation of a new intravenous pump system for prostacyclin treatment in patients with pulmonary arterial hypertension.

R. Ewert, G. Fraedrich, C. Velik-Salchner, 2012, Heart & lung : the journal of critical care.

Care of Patients with Pulmonary Artery Hypertension Subcutaneous implantation of a new intravenous pump system for prostacyclin treatment in patients with pulmonary arterial hypertension

R. Ewert, G. Fraedrich, C. Velik-Salchner, 2012 .

Chronic thromboembolic pulmonary hypertension as a cause of dyspnoea in an older patient with a complex history

C. Kähler, 2009, European Respiratory Review.

Acute right heart syndrome

C. Kähler, S. Desole, 2008 .

Pulmonary arterial hypertension (PAH) in connective tissue diseases.

D. Colleselli, C. Kähler, 2006, Rheumatology.

Targeted therapy of pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018.

S. Rosenkranz, H. Ghofrani, R. Ewert, 2018, International journal of cardiology.

Mediator-dependent effects of pentoxifylline on endothelium for transmigration of neutrophils.

H. Tilg, M. Herold, C. Wiedermann, 1999, Immunopharmacology.

In vivo Release of Vascular Endothelial Growth Factor from Colorectal Carcinomas

G. Gastl, E. Gunsilius, G. Spizzo, 2002, Oncology.

Decrease of respiratory burst in neutrophils of patients with ankylosing spondylitis by combined radon-hyperthermia treatment.

M. Herold, C. Wiedermann, N. Reinisch, 1999, Clinical and experimental rheumatology.

Infliximab Therapy in Pulmonary Sarcoidosis

J. Loeffler-Ragg, P. Heininger, C. Kähler, 2007 .

Secretoneurin--a novel link between the nervous and the immune system. Conservation of the sequence and functional aspects.

R. Fischer‐Colbrie, C. Kähler, 2000, Advances in experimental medicine and biology.

Specific binding of a 125 I -secretoneurin analogue to a human monocytic cell line

C. Wiedermann, R. Fischer‐Colbrie, R. Hogue-Angeletti, 1998, Journal of Neuroimmunology.

Response of vascular smooth muscle cells to the neuropeptide secretoneurin. A functional role for migration and proliferation in vitro.

C. Wiedermann, P. Schratzberger, C. Kähler, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Stimulation of human skin fibroblast migration by the neuropeptide secretoneurin.

C. Wiedermann, N. Reinisch, P. Schratzberger, 1996, European journal of pharmacology.

Attraction of human monocytes by the neuropeptide secretoneurin

R. Kirchmair, C. Wiedermann, N. Reinisch, 1993, FEBS letters.

Inhibition of proliferation and stimulation of migration of endothelial cells by secretoneurin in vitro.

R. Kirchmair, C. Wiedermann, N. Reinisch, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Interaction of substance P with epidermal growth factor and fibroblast growth factor in cyclooxygenase‐dependent proliferation of human skin fibroblasts

M. Herold, C. Wiedermann, N. Reinisch, 1996, Journal of cellular physiology.

Induction of endothelial cell differentiation into capillary-like structures by substance P.

C. Wiedermann, N. Reinisch, P. Schratzberger, 1996, European journal of pharmacology.

Substance P: A competence factor for human fibroblast proliferation that induces the release of growth‐regulatory arachidonic acid metabolites

M. Herold, C. Wiedermann, C. Kähler, 1993, Journal of cellular physiology.

Stimulation of the chemotactic migration of human fibroblasts by substance P.

C. Wiedermann, N. Reinisch, C. Kähler, 1993, European journal of pharmacology.

G. Gastl, E. Gunsilius, G. Stockhammer, 2000 .

Interleukin-1 receptor type I mRNA in mouse brain as affected by peripheral administration of bacterial lipopolysaccharide

C. Dinarello, C. Wiedermann, N. Reinisch, 1994, Neuroscience Letters.

The acute-phase protein α1-antitrypsin inhibits transferrin-receptor binding and proliferation of human skin fibroblasts

W. Vogel, C. Wiedermann, I. Graziadei, 1998 .

Use of fluorochromes in the determination of chemotaxis and haptotaxis of granulocytes by micropore filter assays

C. Wiedermann, P. Schratzberger, C. Kähler, 2004, Annals of Hematology.

Modulation of inflammation by vasoactive intestinal peptide and bombesin: lack of effects on neutrophil apoptosis.

A. Djanani, C. Kähler, 2002, Acta medica Austriaca.

Natural killer cell functions mediated by the neuropeptide substance P

C. Feistritzer, E. Gunsilius, C. Wiedermann, 2003, Regulatory Peptides.

Sensory neuropeptides are potent chemoattractants for human basophils in vitro

C. Kähler, K. Cima, Helene Vogelsinger, 2010, Regulatory Peptides.

Effects of the neuropeptide secretoneurin on natural killer cell migration and cytokine release

D. Colleselli, C. Feistritzer, C. Wiedermann, 2005, Regulatory Peptides.

Influence of neuropeptides on neutrophil adhesion and transmigration through a lung fibroblast barrier in vitro.

C. Wiedermann, C. Kähler, A. Pischel, 2001, Experimental lung research.

Therapie der pulmonal arteriellen Hypertonie (PAH)

W. Haefeli, S. Rosenkranz, H. Ghofrani, 2010, Deutsche medizinische Wochenschrift.

Nasal high-flow versus noninvasive ventilation in patients with chronic hypercapnic COPD

W. Randerath, S. Budweiser, J. Bräunlich, 2019, International journal of chronic obstructive pulmonary disease.

COPD_A_206111 1411..1421

W. Randerath, S. Budweiser, J. Bräunlich, 2019 .

Expression and function of the vascular endothelial growth factor receptor FLT-1 in human eosinophils.

C. Feistritzer, C. Wiedermann, D. Sturn, 2004, American journal of respiratory cell and molecular biology.

Successful treatment of portopulmonary hypertension with the selective endothelin receptor antagonist Sitaxentan

W. Vogel, I. Graziadei, C. Kähler, 2011, Wiener klinische Wochenschrift.

Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation.

E. Gunsilius, C. Prior, C. Kähler, 2001, American journal of respiratory and critical care medicine.

Inhibition of cyclooxygenase (COX)-2 affects endothelial progenitor cell proliferation.

D. Colleselli, B. Mosheimer, K. Bijuklic, 2006, Experimental cell research.

Endothelin-receptor antagonist treatment of portopulmonary hypertension.

W. Jaschke, W. Vogel, I. Graziadei, 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Human and Bovine Endothelial Cell Monolayers Are Differentially Activated for Neutrophil Transmigration by Human Plasma a

S. Kiechl, J. Willeit, C. Wiedermann, 1997, Annals of the New York Academy of Sciences.

Regulation of Myeloid Phagocyte Development and Function by Growth Hormone: A Review

C. Wiedermann, N. Reinisch, H. Braunsteiner, 1993, The Journal of pediatric endocrinology.

Secretoneurin, a novel neuropeptide, is a potent chemoattractant for human eosinophils.

C. Wiedermann, N. Reinisch, P. Schratzberger, 1998, Blood.

Interleukin-8-induced human peripheral blood B-lymphocyte chemotaxis in vitro.

C. Wiedermann, N. Reinisch, P. Schratzberger, 1997, Immunology letters.

A. Geiseler, C. Wiedermann, N. Reinisch, 1998, Journal of Neuroimmunology.

Different patterns of deactivation of Chemotaxis and haptotaxis of human peripheral blood mononuclear leukocytes by soluble and surface‐bound attractants

E. Kowald, C. Wiedermann, N. Reinisch, 1995, Journal of leukocyte biology.

In vivo activation of circulating monocytes by exogenous growth hormone in man

M. Herold, U. Zilian, F. Geisen, 1992, Brain, Behavior, and Immunity.

Signal transduction pathways in directed migration of human monocytes induced by human growth hormone in vitro.

T. Haller, C. Wiedermann, A. Djanani, 2001, International immunopharmacology.

Treatment of pulmonary arterial hypertension(PAH)

W. Haefeli, S. Rosenkranz, H. Ghofrani, 2010 .

Transendothelial migration of leukocytes and signalling mechanisms in response to the neuropeptide secretoneurin

M. Herold, E. Wöll, O. Bechter, 2002, Regulatory Peptides.

Induction of arachidonic acid metabolite release by human fibroblasts in proliferative vitreoretinopathy.

M. Herold, C. Wiedermann, N. Reinisch, 1998, European journal of pharmacology.

Fibroblast growth-promoting activity in proliferative vitreoretinopathy: antagonism by acetylsalicylic acid.

C. Wiedermann, N. Reinisch, J. Troger, 1994, European journal of pharmacology.

Induction of normal human eosinophil migration in vitro by substance P.

C. Wiedermann, N. Reinisch, F. Wiedermann, 1993, Acta haematologica.

Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension.

W. Vogel, M. Kneussl, C. Wiedermann, 2000, Wiener klinische Wochenschrift.

Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells.

W. Prodinger, C. Wiedermann, N. Reinisch, 1997, Journal of immunology.

Secretoneurin-induced in vitro chemotaxis of human monocytes is inhibited by pertussis toxin and an inhibitor of protein kinase C

E. Wöll, C. Wiedermann, N. Reinisch, 1996, Neuroscience Letters.

Pentoxifylline Differentially Regulates Migration and Respiratory Burst Activity of the Neutrophil a

C. Wiedermann, N. Reinisch, P. Schratzberger, 1997, Annals of the New York Academy of Sciences.

Deactivation of chemotaxis of human neutrophils by priming with secretogranin II-derived secretoneurin

C. Wiedermann, N. Reinisch, P. Schratzberger, 1996, Regulatory Peptides.

Human chorionic gonadotrophin: a chemoattractant for human blood monocytes, neutrophils and lymphocytes.

C. Wiedermann, N. Reinisch, C. Kähler, 1994, The Journal of endocrinology.

Increased numbers of endothelial progenitor cells in peripheral blood and tumor specimens in non-small cell lung cancer: a methodological challenge and an ongoing debate on the clinical relevance.

T. Schmid, S. Skvortsov, A. Pircher, 2008, Oncology reports.

Effect of inhibitors of Na+/H+‐exchange and gastric H+/K+ ATPase on cell volume, intracellular pH and migration of human polymorphonuclear leucocytes

H. Rossmann, H. Zwierzina, F. Lang, 1998, British journal of pharmacology.

Peripheral infusion of rat bone marrow derived endothelial progenitor cells leads to homing in acute lung injury

A. Wendel, J. Hamacher, H. Niederegger, 2007, Respiratory research.

CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer

T. Schmid, S. Dirnhofer, W. Hilbe, 2004, Journal of Clinical Pathology.

Mevalonate-dependent inhibition of transendothelial migration and chemotaxis of human peripheral blood neutrophils by pravastatin.

C. Wiedermann, N. Reinisch, P. Schratzberger, 1997, Circulation research.

Endothelial Progenitor Cells: Current Issues on Characterization and Challenging Clinical Applications

A. Pircher, W. Hilbe, J. Pratschke, 2011, Stem Cell Reviews and Reports.

A soluble gradient of the neuropeptide secretoneurin promotes the transendothelial migration of monocytes in vitro.

C. Wiedermann, N. Reinisch, S. Dunzendorfer, 1999, European journal of pharmacology.

Diagnostic and Therapeutic Challenges of a Large Pleural Inflammatory Myofibroblastic Tumor

J. Bodner, M. Steurer, B. Zelger, 2012, Case reports in pulmonology.

Release of chemoattractants for human monocytes from endothelial cells by interaction with neutrophils.

M. Herold, C. Wiedermann, N. Reinisch, 1998, Cardiovascular research.

Secretoneurin: a new player in angiogenesis and chemotaxis linking nerves, blood vessels and the immune system.

R. Kirchmair, A. Saria, C. Wiedermann, 2005, Current protein & peptide science.

[Quality of life in pulmonal arterial hypertension and in chronic thromboembolic pulmonary hypertension].

R. Speich, M. Puhan, M. Lichtblau, 2014, Deutsche medizinische Wochenschrift.

The German adaptation of the Cambridge pulmonary hypertension outcome review (CAMPHOR)

R. Speich, S. Ulrich, E. Grünig, 2012, Health and Quality of Life Outcomes.

[Supportive therapy in pulmonary arterial hypertension].

R. Speich, M. Lichtblau, K. Olsson, 2014, Deutsche medizinische Wochenschrift.

Aktuelle Therapieoptionen bei der COPD

A. Gillissen, A. Koczulla, C. Kähler, 2017, MMW - Fortschritte der Medizin.

Phenotypes of COPD in an Austrian population

A. Valipour, O. Burghuber, B. Lamprecht, 2018, Wiener klinische Wochenschrift.

Successful switch from inhalative iloprost to oral bosentan in portopulmonary hypertension associated with liver cirrhosis

W. Vogel, D. Colleselli, H. Alber, 2004, Wiener klinische Wochenschrift.

Postprandial, but not postabsorptive low-density lipoproteins increase the expression of intercellular adhesion molecule-1 in human aortic endothelial cells.

R. Kirchmair, S. Kaser, J. Patsch, 2006, Atherosclerosis.

The neuropeptide secretoneurin stimulates adhesion of human monocytes to arterial and venous endothelial cells in vitro

C. Wiedermann, C. Kähler, G. Kaufmann, 2002, Regulatory Peptides.

Effects of thalidomide on neutrophil respiratory burst, chemotaxis, and transmigration of cytokine- and endotoxin-activated endothelium

C. Wiedermann, N. Reinisch, P. Schratzberger, 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

Plasma-Induced Endothelial Activation Associated with Incident Atherosclerosis: Prospective Results from the Bruneck Study

S. Kiechl, J. Willeit, J. Patsch, 2000, Journal of cardiovascular risk.

Augmentation of tumor necrosis factor-alpha-induced priming of fMet-Leu-Phe-stimulated neutrophils by pentoxifylline.

C. Wiedermann, N. Reinisch, P. Schratzberger, 1997, Immunology letters.

[Combination therapy for the treatment of pulmonary arterial hypertension].

C. Kähler, 2009, Deutsche medizinische Wochenschrift.

Endothelial Progenitor Cells: Current Issues on Characterization and Challenging Clinical Applications

A. Pircher, W. Hilbe, J. Pratschke, 2012, Stem Cell Reviews and Reports.

Review of IPF diagnosis and management recommendations in Europe.

V. Cottin, M. Sköld, E. Bendstrup, 2013, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

Contribution of endothelial cells of hematopoietic origin to blood vessel formation.

G. Gastl, E. Gunsilius, H. Duba, 2001, Circulation research.

Sensory neuropeptides are potent chemoattractants for human basophils in vitro

C. Kähler, K. Cima, Helene Vogelsinger, 2010, Regulatory Peptides.

Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation.

E. Gunsilius, C. Prior, C. Kähler, 2001, American journal of respiratory and critical care medicine.

Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe night time hypoxia.

C. Prior, C. Kähler, C. Molnar, 2003, American journal of respiratory and critical care medicine.

Long term home high flow nasal cannula therapy in hypercapnic and hypoxic patients after non-invasive ventilation failure – a retrospective analysis

F. Baty, C. Kähler, C. Horvath, 2019, Noninvasive ventilatory support.

Activation of the NOTCH signaling pathway stimulates migration of human B-lymphocytes

A. Holzer, C. Kähler, K. Watzinger, 2015 .

Management of respiratory deterioration in a pregnant patient with severe kyphoscoliosis by non-invasive positive pressure ventilation.

B. Högl, J. Hamacher, C. Brezinka, 2002, Wiener klinische Wochenschrift.

Staurosporine-Dependent Activation of Human Endothelial Cell Monolayers for Neutrophil Adherence by Secretoneurin

C. Wiedermann, N. Reinisch, P. Schratzberger, 1997, Peptides.